Treatment of metastatic renal cell carcinoma with subcutaneous recombinant interleukin-2 and interferon alpha
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Interferon alpha; Interleukin-2
- Indications Renal cancer
- Focus Therapeutic Use
- 19 Dec 2013 Biomarkers information updated
- 03 Sep 2005 New trial record.